File: The treatment is less toxic than traditional chemotherapy because it more selectively targets cancerous cells, blocking their ability to multiply.CHICAGO - A new form of drug drastically improves survival rates of young women with the most common form of breast cancer, researchers said on Saturday, citing the results of an international clinical trial.
"You actually can get synergy or a better response, better cancer kill, by adding one of these cell cycle inhibitors" on top of the hormone suppression, Hurvitz said. The trial, which looked at more than 670 cases, included only women under the age of 59 who had advanced cancer -- stage four -- for which they had not received prior hormone-blocking therapy.
"That's what makes us so excited because it's a therapy that's affecting so many patients with advanced disease."
Must be better than the alternative...